ISHARES INC - US INTL HGH YLD (GHYG)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / US INTL HGH YLD
Symbol
GHYG
Price per share
$46.16
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
2,906,882
Total reported value
$135,251,506
% of total 13F portfolios
0%
Share change
+203,622
Value change
+$9,481,926
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, ISHARES INC - US INTL HGH YLD (GHYG) has 42 institutional shareholders filing 13F forms. They hold 2,906,882 shares. .

Institutional Holders of ISHARES INC - US INTL HGH YLD (GHYG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 403,186 $18,612,692 +$11,771,728 $46.16 1
2025 Q3 2,906,882 $135,251,506 +$9,481,926 $46.54 42
2025 Q2 2,695,324 $124,832,518 -$9,425,193 $46.31 45
2025 Q1 2,901,978 $129,322,314 +$22,416,078 $44.56 47
2024 Q4 2,399,355 $105,852,654 -$1,405,221 $44.07 45
2024 Q3 2,137,168 $97,810,970 +$2,716,001 $45.78 48
2024 Q2 2,081,091 $90,976,928 +$8,921,067 $43.71 47
2024 Q1 1,865,259 $82,338,941 +$41,251 $44.15 46
2023 Q4 23,656 $1,046,418 +$1,046,418 $44.23 1
2023 Q3 2,254,384 $93,609,441 +$9,766,934 $41.51 46
2023 Q2 1,923,104 $81,684,997 -$10,645,967 $42.48 42
2023 Q1 2,173,410 $93,050,420 +$31,605,964 $42.82 37
2022 Q4 1,435,446 $59,426,517 -$9,226,403 $41.40 29
2022 Q3 1,767,104 $68,759,000 +$20,520,077 $38.92 26
2022 Q2 1,241,605 $50,444,000 -$19,302,712 $40.63 29
2022 Q1 1,556,467 $71,848,000 -$23,835,569 $46.16 30
2021 Q4 2,192,813 $108,157,000 -$11,746,046 $49.29 36
2021 Q3 2,210,246 $110,638,968 +$3,345,072 $50.05 37
2021 Q2 2,143,357 $109,031,148 +$8,669,412 $50.86 37
2021 Q1 1,958,274 $98,304,898 +$5,153,992 $50.19 37
2020 Q4 1,649,903 $83,707,488 +$5,396,514 $50.74 34
2020 Q3 1,680,303 $80,686,299 +$11,294,657 $48.02 31
2020 Q2 1,457,339 $67,387,852 -$4,543,394 $46.27 33
2020 Q1 1,561,836 $66,019,000 -$10,649,871 $42.28 33
2019 Q4 1,736,474 $86,524,000 -$4,350,263 $49.83 43
2019 Q3 1,822,934 $88,930,428 -$1,177,155 $48.79 41
2019 Q2 1,847,185 $91,073,000 +$15,087,621 $49.33 39
2019 Q1 1,527,989 $74,642,000 -$16,799,287 $48.84 41
2018 Q4 1,866,543 $85,937,000 -$27,812,376 $46.03 43
2018 Q3 2,430,950 $120,394,000 +$12,362,836 $49.53 44
2018 Q2 2,182,814 $106,933,000 +$3,846,455 $48.99 47
2018 Q1 2,100,057 $105,285,000 +$14,869,962 $50.11 49
2017 Q4 1,802,502 $90,941,000 -$8,709,756 $50.45 41
2017 Q3 1,897,848 $97,584,000 +$20,081,819 $51.42 32
2017 Q2 1,553,628 $78,444,000 -$3,340,192 $50.49 33
2017 Q1 1,620,045 $79,952,000 +$39,887,149 $49.36 31
2016 Q4 814,365 $39,481,000 -$7,801,611 $48.48 29
2016 Q3 972,093 $48,098,000 -$10,365,720 $49.49 26
2016 Q2 1,202,199 $57,233,000 +$4,979,130 $47.61 30
2016 Q1 1,092,491 $50,449,000 -$4,753,323 $46.18 21
2015 Q4 1,197,390 $53,489,918 +$5,146,408 $44.62 28
2015 Q3 1,083,109 $50,592,000 +$18,301,614 $46.72 20
2015 Q2 884,217 $43,804,278 -$740,948 $49.54 25
2015 Q1 901,345 $44,564,680 +$8,043,628 $49.45 23
2014 Q4 740,382 $36,823,306 +$34,624,301 $49.73 26
2014 Q3 240 $12,000 -$1,137,000 $50.00 1
2014 Q2 20,935 $1,149,000 $0 $54.90 2
2014 Q1 20,935 $1,138,000 +$186,000 $54.39 2